Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive function in dialysis patients.

Arema A Pereira1, Daniel E Weiner, Tammy Scott

  • 1Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|March 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle Cramp Rate, Severity and Burden in Maintenance Hemodialysis Patients: A Yearlong Multicenter Quality Improvement Initiative.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Medication Burden and Regimen Complexity Among Dialysis Patients from 2003 to 2024.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Dialysis Facility Closures: Fraying a Fragile Lifeline for People With Kidney Failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM).

Kidney360·2026
Same author

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Kidney360·2026
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Palliative Dialysis: Putting the Person First in Dialysis Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Pathophysiology of Ketoacidosis: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

Cognitive impairment is common in dialysis patients, often linked to cerebrovascular disease. Understanding risk factors and brain changes is crucial for improving care and quality of life for this aging population.

Area of Science:

  • Nephrology
  • Neurology
  • Geriatrics

Background:

  • Limited research exists on cognitive function in dialysis patients.
  • Cognitive impairment negatively impacts quality of life, healthcare utilization, and adherence to medical advice.
  • The aging dialysis population exacerbates concerns about cognitive decline.

Purpose of the Study:

  • To review the prevalence and risk factors of cognitive impairment in dialysis patients.
  • To explore the role of cerebrovascular disease in cognitive decline among this population.
  • To discuss potential interventions to mitigate cognitive impairment.

Main Methods:

  • Literature review focusing on cognitive function, cerebrovascular disease, and dialysis.
  • Analysis of structural brain abnormalities and neurocognitive changes in prior studies.

Related Experiment Videos

  • Synthesis of risk factors influencing cognitive function in dialysis patients.

    • Main Results:

    • Cerebrovascular disease is identified as a significant contributor to cognitive impairment.
    • Structural brain abnormalities are frequently observed in dialysis patients.
    • Specific neurocognitive deficits have been documented in existing research.

    Conclusions:

    • Further research is essential to fully understand and address cognitive impairment in dialysis patients.
    • Identifying and managing risk factors, particularly cerebrovascular disease, is critical.
    • Developing effective strategies to reduce cognitive decline is a priority for this growing demographic.